# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Goldman Sachs analyst Matthew Sykes maintains Singular Genomics Sys (NASDAQ:OMIC) with a Neutral and lowers the price target...
Singular Genomics Sys (NASDAQ:OMIC) reported quarterly losses of $(0.34) per share which beat the analyst consensus estimate of...
Singular Genomics Sys (NASDAQ:OMIC) reported quarterly losses of $(0.32) per share which beat the analyst consensus estimate of...
Companies Reporting Before The Bell • Niu Techs (NASDAQ:NIU) is expected to report earnings for its fourth quarter.
Singular Genomics Systems, Inc. (NASDAQ:OMIC), a company leveraging novel next-generation sequencing (NGS) and spatial multiomi...
Goldman Sachs analyst Matthew Sykes maintains Singular Genomics Sys (NASDAQ:OMIC) with a Neutral and lowers the price target...